MALAFRONTE MICHAEL W

Director Michael W Malafronte bought 36,036 shares at blended average $100.88 for $3.6M on 2026-03-10/11 at newly-listed CVSA.

Michael W Malafronte, a director at Covista Inc., made 3 separate purchases totaling 36,036 shares for $3,635,413.74 across two days immediately following the company's recent listing (13 trading days old as of filing). The purchases at $100.86–$100.94 represent accumulation just 3 cents below the current price of $103.84, moving his position from a net short of 10,641 shares to a net long of 25,395 shares. Given CVSA's strong recent fundamentals—revenue of $503,385,000.00, net income of $76,376,000.00, and P/E of 14.15—this substantial director purchase in the early trading window of a newly listed security merits investor attention as a potential signal of insider confidence in the valuation during the initial price-discovery phase.

Director Malafronte buys 1,200 shares of CVSA at $97.97 (first purchase); stock up to $102.04 in 2 days

Michael W. Malafronte, a director of Covista Inc., made his initial share purchase of 1,200 shares at $97.97 on 2026-03-03 for $117,564.00, building an opening position from zero holdings. Two trading days later, the stock moved to $102.04, representing a modest gain relative to purchase price. Covista presents solid fundamentals with quarterly revenue of $503,385,000.00, net income of $76,376,000.00, annual revenue growth of +12.8%, and a P/E ratio of 13.90 across a $3.5B market cap. The recent listing status (8 trading days) means this acquisition occurs in an early public-market window when director positioning decisions may reflect initial confidence in the company's public-market trajectory.

ATGE Director MALAFRONTE buys 1.0K shares at $91.85; stock down 40.3% from 52-week high, but fundamentals solid (13.25 P/E, +12.8% revenue growth).

Director Michael W. Malafronte purchased 1,000 shares of Adtalem Global Education Inc. on 2025-11-04 at $91.85, adding to a 100.4K share holding. The transaction occurs against a backdrop of significant near-term price deterioration: the stock is trading at $92.22, down 40.3% from its 52-week high of $154.45 and down 37.9% over the past 30 days. However, the company's fundamentals remain relatively intact, with a P/E of 13.25, annual revenue growth of +12.8%, and latest quarterly revenue of $462.3M with net income of $61.8M. Malafronte's prior buy at this ticker on 2025-03-07 demonstrated strong timing, with a 90d return of +46.6%, consistent with his cross-ticker track record of 100.00% 90-day win rate on buys (avg 90d return +46.6%). The purchase into an oversold price environment, paired with his demonstrated accuracy in prior ATGE trading, warrants attention from investors monitoring director-level conviction at depressed valuations.

ATGE Director MALAFRONTE buys 1,000 shares at $87.21; stock down 17.5% from 52-week high

Michael W. Malafronte, a Director at Adtalem Global Education Inc., purchased 1,000 shares at $87.21 on March 7, 2025, increasing his holdings from 98,445 to 99,445 shares. The purchase occurred against a backdrop of recent weakness: the stock has declined 17.5% from its 52-week high of $110.11 and is trading 17.5% below price levels seen 30 days ago. Despite this near-term decline, the company's fundamentals remain solid—annual revenue growth of 9.2%, a P/E of 16.25, and quarterly net income of $75.9M on revenue of $447.7M—suggesting any valuation compression is driven by market sentiment rather than operational deterioration. The transaction itself is modest in scale (1,000 shares representing a 1.0% increase to his position), and without evidence of concurrent acquisitions by other insiders or a pattern of prior buy activity at this price level, this single discretionary purchase provides limited signal regarding forward guidance or management conviction on its own.